Roivant Sciences Ltd. (ROIV) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.44 million versus the consensus estimate of $2.32 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil shares drop as crude oil prices tumble
- Snap finalizing settlement to avoid LA trial on addiction claim - Bloomberg
- Axsome Therapeutics (AXSM) PT Lowered to $235 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
